These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 2770329

  • 1. Whole blood assay for NK activity in splenectomized and non-splenectomized hairy cell leukemia patients during IFN-alpha-2b treatment.
    Nielsen B, Hokland P, Ellegaard J, Hasselbalch H, Hokland M.
    Leuk Res; 1989; 13(6):451-6. PubMed ID: 2770329
    [Abstract] [Full Text] [Related]

  • 2. Interleukin 2- and interferon alpha induced natural killer cell activity as a marker of progression in hairy cell leukemia.
    Bigda J, Mysliwska J, Baran W, Hellmann A, Mysliwski A.
    Leuk Lymphoma; 1993 Mar; 9(4-5):371-6. PubMed ID: 8348073
    [Abstract] [Full Text] [Related]

  • 3. The beneficial effects of alpha-interferon in hairy cell leukemia are not attributable to NK cell-mediated cytotoxicity.
    Griffiths SD, Cawley JC.
    Leukemia; 1987 Apr; 1(4):372-6. PubMed ID: 3669763
    [Abstract] [Full Text] [Related]

  • 4. Immunological recovery and dose evaluation in IFN-alpha treatment of hairy cell leukemia: analysis of leukocyte differentiation antigens, NK and 2',5'-oligoadenylate synthetase activity.
    Nielsen B, Hokland M, Justesen J, Hasselbalch H, Ellegaard J, Hokland P.
    Eur J Haematol; 1989 Jan; 42(1):50-9. PubMed ID: 2914594
    [Abstract] [Full Text] [Related]

  • 5. Treatment of hairy cell leukemia with granulocyte colony-stimulating factor and recombinant consensus interferon or recombinant interferon-alpha-2b.
    Glaspy JA, Souza L, Scates S, Narachi M, Blatt L, Ambersley J, Golde DW.
    J Immunother (1991); 1992 Apr; 11(3):198-208. PubMed ID: 1381218
    [Abstract] [Full Text] [Related]

  • 6. Combination treatment of 2-chlorodeoxyadenosine and type I interferon on hairy cell leukemia-like cells: cytotoxic effect and MHC-unrestricted killer cell regulation.
    Reiter Z, Tomson S, Ozes ON, Taylor MW.
    Blood; 1993 Apr 01; 81(7):1699-708. PubMed ID: 8096405
    [Abstract] [Full Text] [Related]

  • 7. Natural killer cell function and malignant cell phenotype in hairy cell leukaemia.
    Ogmundsdóttir HM, Thorsteinsson L, Sigfússon A, Sveinsdóttir S, Björnsson S, Eyjólfsson G, Jóhannesson GM, Jensson O.
    APMIS; 1992 Jan 01; 100(1):10-20. PubMed ID: 1536717
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Human recombinant interferon-alpha-2 in the treatment of patients with hairy cell leukemia.
    Skotnicki AB, Wolska-Smolen T, Blicharski J, Zduńczyk A, Sasiadek U, Pituch-Noworolska A.
    Cancer Detect Prev; 1988 Jan 01; 12(1-6):511-22. PubMed ID: 3180143
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Peripheral and intrasplenic platelet kinetics and bone marrow megakaryopoiesis in alpha-2b-interferon treated hairy cell leukemia.
    Wadenvik H, Braide I, Ridell B, Kutti J, Jacobsson S, Revesz P.
    Leuk Res; 1994 Aug 01; 18(8):569-75. PubMed ID: 8065159
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.